Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | ATM | Q13315 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | PRKCA | P17252 | 3/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.53 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.49 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.49 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.49 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9932773 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL489650 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL9932933 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL9933237 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL20767375 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL9934466 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL28846621 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL3759681 | 0.98 | CYP3A4 (0.69) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL3759279 | 0.98 | CYP3A4 (0.69) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL3757067 | 0.98 | CYP3A4 (0.69) | CYP3A4TSHRATMTDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263620-A1 | LUBRICANT COMPOSITION COMPRISING TRACTION COEFFICIENT ADDITIVE | CARGILL BIOINDUSTRIAL UK LTD (GB) | 2025-08-21 | — | — | US | claimed |
| US-20230050775-A1 | HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2023-02-16 | — | — | US | claimed |
| EP-4082522-A1 | HAIR COSMETIC COMPOSITION | Kao Corporation (JP) | 2022-11-02 | — | — | EP | claimed |
| CN-114867462-A | Hair cosmetic | 花王株式会社 | 2022-08-05 | — | — | CN | claimed |
| WO-2026105853-A1 | COSMETIC COMPOSITION AND METHOD FOR PRODUCING SAME | 株式会社ダイセル | 2026-05-21 | — | — | WO | disclosed |
| WO-2026105854-A1 | COSMETIC COMPOSITION AND METHOD FOR PRODUCING SAME | 株式会社ダイセル | 2026-05-21 | — | — | WO | disclosed |
| EP-4714424-A1 | POWDER COMPOSITION AND COSMETIC USING SAME | Tayca Corporation (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-20260078211-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESS THEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | DOW TORAY CO LTD (JP) | 2026-03-19 | — | — | US | disclosed |
| EP-4710926-A1 | TOPICAL COMPOSITION | Api Co., Ltd. (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-12569428-B2 | Oil-in-water cleansing cosmetic composition | DOW TORAY CO., LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| EP-3838257-B1 | COSMETIC CONTAINING A CARBOXYLIC ACID MODIFIED SILICONE | DOW TORAY CO LTD (JP) | 2026-01-07 | — | — | EP | disclosed |
| EP-3838249-B1 | OIL-IN-WATER EMULSION COSMETIC COMPOSITION CONTAINING A CARBOXYLIC ACID MODIFIED SILICONE | DOW TORAY CO LTD (JP) | 2026-01-07 | — | — | EP | disclosed |
| EP-3960152-A1 | COSMETIC PREPARATION | Dow Toray Co., Ltd. (JP) | 2022-03-02 | — | — | EP | disclosed |
| US-11260007-B2 | Cosmetic composition comprising particles containing high content of ceramide and method for preparing same | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2022-03-01 | — | — | US | disclosed |
| CN-114073648-A | Cosmetic composition comprising natural polymers | 株式会社LG生活健康 | 2022-02-22 | — | — | CN | disclosed |
| CN-114073652-A | Polyglyceryl isostearate | 太阳化学株式会社 | 2022-02-22 | — | — | CN | disclosed |
| CN-114040746-A | Oil-in-water type cleansing cosmetic | 陶氏东丽株式会社 | 2022-02-11 | — | — | CN | disclosed |
| WO-2022030569-A1 | AGENT FOR IMPROVING QUALITY OF SLEEP | エステー株式会社 | 2022-02-10 | — | — | WO | disclosed |
| EP-3950727-A1 | COPOLYMER HAVING CARBOSILOXANE DENDRIMER STRUCTURE, AND COMPOSITION, COSMETIC INGREDIENT, COATING FORMING AGENT, AND COSMETIC CONTAINING SAME | Dow Toray Co., Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| EP-3950071-A1 | CORE-SHELL STRUCTURE, PREPARATION, MEDICINE FOR EXTERNAL APPLICATION, TAPE AGENT AND COSMETIC PRODUCT | SEKISUI CHEMICAL CO., LTD. (JP) | 2022-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078211-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESS THEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | FOXM1, FOXK1, TAF1L | CYP3A4 2713/4885TSHR 2100/4885ATM 361/4885 |
| US-12569428-B2 | Oil-in-water cleansing cosmetic composition | SGMS2, SGMS1, CUTA | CYP3A4 4636/4885TSHR 1036/4885ATM 84/4885 |
| US-20230050775-A1 | HAIR COSMETIC COMPOSITION | CUTA, SHH, POF1B | CYP3A4 3208/4885TSHR 2804/4885ATM 3060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.